(Q51729617)

10 April 2018

title

CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma. (English)

1 reference

10 April 2018

author

Weide Zhong

10

1 reference

10 April 2018

author name string

Yong-kang Ye

1

1 reference

10 April 2018

Xue-cheng Bi

2

1 reference

10 April 2018

Hui-chan He

3

1 reference

10 April 2018

Zhao-dong Han

4

1 reference

10 April 2018

Qi-shan Dai

5

1 reference

10 April 2018

Yu-xiang Liang

6

1 reference

10 April 2018

Guo-hua Zeng

7

1 reference

10 April 2018

Wei-jun Qin

8

1 reference

10 April 2018

Zhi-nan Chen

9

1 reference

10 April 2018

publication date

13 January 2010

1 reference

10 April 2018

Clinical and Experimental Medicine

published in

1 reference

10 April 2018

volume

10

1 reference

10 April 2018

page(s)

153-158

1 reference

10 April 2018

issue

3

1 reference

10 April 2018

https://scigraph.springernature.com/pub.10.1007/s10238-009-0088-3

exact match

0 references

cites work

Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10238-009-0088-3

Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis

21 January 2018

1 reference

12 December 2020

Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases

1 reference

12 December 2020

Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma

1 reference

12 December 2020

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

12 December 2020

Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity

1 reference

12 December 2020

Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

1 reference

12 December 2020

Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer

1 reference

12 December 2020

Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.

1 reference

12 December 2020

Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis

1 reference

12 December 2020

Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies

1 reference

12 December 2020

Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma

1 reference

12 December 2020

Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy

1 reference

12 December 2020

Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya.

1 reference

12 December 2020

Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value.

1 reference

12 December 2020

Current status of urinary cytology in the evaluation of bladder neoplasms

1 reference

12 December 2020

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

12 December 2020

Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis

1 reference

12 December 2020

Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma

1 reference

12 December 2020

Cystectomy for bladder cancer: a contemporary series

1 reference

12 December 2020

Comparison of screening methods in the detection of bladder cancer

1 reference

12 December 2020

Telomerase: its clinical relevance in the diagnosis of bladder cancer

1 reference

12 December 2020

Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa

1 reference

12 December 2020

Monoclonal 3c6f9 distribution in human breast carcinomas: image cytometry of immunocytochemical assays

1 reference

12 December 2020

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma

1 reference

12 December 2020

Urine telomerase: an important marker in the diagnosis of bladder cancer

1 reference

12 December 2020

Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients

1 reference

12 December 2020

Bladder cancer: epidemiology, staging and grading, and diagnosis.

1 reference

12 December 2020

10.1007/S10238-009-0088-3

Identifiers

DOI

1 reference

10 April 2018

PubMed ID

20069333

1 reference

10 April 2018